-
1
-
-
84855792427
-
Cancer statistics, 2012
-
10.3322/caac.20138 22237781
-
Cancer statistics, 2012. Siegel R, Naishadham D, Jemal A, CA Cancer J Clin 2012 62 10 29 10.3322/caac.20138 22237781
-
(2012)
CA Cancer J Clin
, vol.62
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
29144475553
-
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials
-
DOI 10.1016/S0140-6736(05)67887-7, PII S0140673605678877
-
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, et al. Lancet 2005 366 2087 2106 16360786 (Pubitemid 41797643)
-
(2005)
Lancet
, vol.366
, Issue.9503
, pp. 2087-2106
-
-
Abe, O.1
Abe, R.2
Enomoto, K.3
Kikuchi, K.4
Koyama, H.5
Masuda, H.6
Nomura, Y.7
Sakai, K.8
Sugimachi, K.9
Tominaga, T.10
Uchino, J.11
Yoshida, M.12
Haybittle, J.L.13
Davies, C.14
Harvey, V.J.15
Holdaway, T.M.16
Kay, R.G.17
Mason, B.H.18
Forbes, J.F.19
Wilcken, N.20
Gnant, M.21
Jakesz, R.22
Ploner, M.23
Yosef, H.M.A.24
Focan, C.25
Lobelle, J.P.26
Peek, U.27
Oates, G.D.28
Powell, J.29
Durand, M.30
Mauriac, L.31
Di Leo, A.32
Dolci, S.33
Piccart, M.J.34
Masood, M.B.35
Parker, D.36
Price, J.J.37
more..
-
3
-
-
0033562626
-
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
-
DOI 10.1016/S0140-6736(98)09201-0
-
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, et al. Lancet 1999 353 1641 1648 10.1016/S0140-6736(98)09201-0 10335782 (Pubitemid 29224519)
-
(1999)
Lancet
, vol.353
, Issue.9165
, pp. 1641-1648
-
-
Overgaard, M.1
Jensen, M.-B.2
Overgaard, J.3
Hansen, P.S.4
Rose, C.5
Andersson, M.6
Kamby, C.7
Kjaer, M.8
Gadeberg, C.C.9
Rasmussen, B.B.10
Blichert-Toft, M.11
Mouridsen, H.T.12
-
4
-
-
13744263454
-
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial
-
DOI 10.1093/jnci/djh297
-
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, et al. J Natl Cancer Inst 2005 97 116 126 10.1093/jnci/djh297 15657341 (Pubitemid 40277091)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.2
, pp. 116-126
-
-
Ragaz, J.1
Olivotto, I.A.2
Spinelli, J.J.3
Phillips, N.4
Jackson, S.M.5
Wilson, K.S.6
Knowling, M.A.7
Coppin, C.M.L.8
Weir, L.9
Gelmon, K.10
Le, N.11
Durand, R.12
Coldman, A.J.13
Manji, M.14
-
5
-
-
0035829843
-
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation
-
10.1056/NEJMoa010874 11794170
-
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, et al. N Engl J Med 2001 345 1378 1387 10.1056/NEJMoa010874 11794170
-
(2001)
N Engl J Med
, vol.345
, pp. 1378-1387
-
-
Bartelink, H.1
Horiot, J.C.2
Poortmans, P.3
Struikmans, H.4
Van Den Bogaert, W.5
Barillot, I.6
Fourquet, A.7
Borger, J.8
Jager, J.9
Hoogenraad, W.10
-
6
-
-
77954641944
-
Radiation-induced cell death mechanisms
-
10.1007/s13277-010-0042-8 20490962
-
Radiation-induced cell death mechanisms. Eriksson D, Stigbrand T, Tumour Biol 2010 31 363 372 10.1007/s13277-010-0042-8 20490962
-
(2010)
Tumour Biol
, vol.31
, pp. 363-372
-
-
Eriksson, D.1
Stigbrand, T.2
-
7
-
-
0032080807
-
Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy
-
Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. Rupnow BA, Murtha AD, Alarcon RM, Giaccia AJ, Knox SJ, Cancer Res 1998 58 1779 1784 9581811 (Pubitemid 28217445)
-
(1998)
Cancer Research
, vol.58
, Issue.9
, pp. 1779-1784
-
-
Rupnow, B.A.1
Murtha, A.D.2
Alarcon, R.M.3
Giaccia, A.J.4
Knox, S.J.5
-
8
-
-
34547603628
-
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to abt-737 and conventional chemotherapeutic agents
-
DOI 10.1016/j.ccr.2007.07.001, PII S1535610807002000
-
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A, Cancer Cell 2007 12 171 185 10.1016/j.ccr.2007.07.001 17692808 (Pubitemid 47199122)
-
(2007)
Cancer Cell
, vol.12
, Issue.2
, pp. 171-185
-
-
Deng, J.1
Carlson, N.2
Takeyama, K.3
Dal Cin, P.4
Shipp, M.5
Letai, A.6
-
9
-
-
0033179760
-
BCL-2 family members and the mitochondria in apoptosis
-
BCL-2 family members and the mitochondria in apoptosis. Gross A, McDonnell JM, Korsmeyer SJ, Genes Dev 1999 13 1899 1911 10.1101/gad.13.15.1899 10444588 (Pubitemid 29407357)
-
(1999)
Genes and Development
, vol.13
, Issue.15
, pp. 1899-1911
-
-
Gross, A.1
McDonnell, J.M.2
Korsmeyer, S.J.3
-
10
-
-
33846807693
-
Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor
-
16909121
-
Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. An J, Chervin AS, Nie A, Ducoff HS, Huang Z, Oncogene 2006 26 652 661 16909121
-
(2006)
Oncogene
, vol.26
, pp. 652-661
-
-
An, J.1
Chervin, A.S.2
Nie, A.3
Ducoff, H.S.4
Huang, Z.5
-
11
-
-
35648977549
-
Downregulation of BCL-2 Induces Downregulation of Carbonic Anhydrase IX, Vascular Endothelial Growth Factor, and pAkt and Induces Radiation Sensitization
-
DOI 10.1016/j.urology.2007.06.1118, PII S0090429507018006
-
Downregulation of BCL-2 Induces Downregulation of Carbonic Anhydrase IX, Vascular Endothelial Growth Factor, and pAkt and Induces Radiation Sensitization. Anai S, Shiverick K, Medrano T, Nakamura K, Goodison S, Brown B, Rosser C, Urology 2007 70 832 837 10.1016/j.urology.2007.06.1118 17991582 (Pubitemid 350030244)
-
(2007)
Urology
, vol.70
, Issue.4
, pp. 832-837
-
-
Anai, S.1
Shiverick, K.2
Medrano, T.3
Nakamura, K.4
Goodison, S.5
Brown, B.D.6
Rosser, C.J.7
-
12
-
-
77955711901
-
Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells
-
10.1016/j.radonc.2010.06.005 20638740
-
Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells. Khan Z, Khan N, Tiwari RP, Patro IK, Prasad GB, Bisen PS, Radiother Oncol 2010 96 267 273 10.1016/j.radonc.2010.06. 005 20638740
-
(2010)
Radiother Oncol
, vol.96
, pp. 267-273
-
-
Khan, Z.1
Khan, N.2
Tiwari, R.P.3
Patro, I.K.4
Prasad, G.B.5
Bisen, P.S.6
-
13
-
-
84863073515
-
Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells
-
22209830
-
Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells. Liu ZG, Liu L, Xu LH, Yi W, Tao YL, Tu ZW, Li MZ, Zeng MS, Xia YF, Oncol Rep 2012 27 1116 1122 22209830
-
(2012)
Oncol Rep
, vol.27
, pp. 1116-1122
-
-
Liu, Z.G.1
Liu, L.2
Xu, L.H.3
Yi, W.4
Tao, Y.L.5
Tu, Z.W.6
Li, M.Z.7
Zeng, M.S.8
Xia, Y.F.9
-
14
-
-
20444486559
-
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
-
DOI 10.1038/nature03579
-
An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al. Nature 2005 435 677 681 10.1038/nature03579 15902208 (Pubitemid 40825512)
-
(2005)
Nature
, vol.435
, Issue.7042
, pp. 677-681
-
-
Oltersdorf, T.1
Elmore, S.W.2
Shoemaker, A.R.3
Armstrong, R.C.4
Augeri, D.J.5
Belli, B.A.6
Bruncko, M.7
Deckwerth, T.L.8
Dinges, J.9
Hajduk, P.J.10
Joseph, M.K.11
Kitada, S.12
Korsmeyer, S.J.13
Kunzer, A.R.14
Letai, A.15
Li, C.16
Mitten, M.J.17
Nettesheim, D.G.18
Ng, S.19
Nimmer, P.M.20
O'Connor, J.M.21
Oleksijew, A.22
Petros, A.M.23
Reed, J.C.24
Shen, W.25
Tahir, S.K.26
Thompson, C.B.27
Tomaselli, K.J.28
Wang, B.29
Wendt, M.D.30
Zhang, H.31
Fesik, S.W.32
Rosenberg, S.H.33
more..
-
15
-
-
74949091177
-
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy
-
20021437
-
Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy. Richardson A, Kaye SB, Curr Mol Pharmacol 2008 1 244 254 20021437
-
(2008)
Curr Mol Pharmacol
, vol.1
, pp. 244-254
-
-
Richardson, A.1
Kaye, S.B.2
-
16
-
-
54249093808
-
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737
-
10.1158/0008-5472.CAN-08-1418 18829556
-
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737. Kutuk O, Letai A, Cancer Res 2008 68 7985 7994 10.1158/0008-5472.CAN-08-1418 18829556
-
(2008)
Cancer Res
, vol.68
, pp. 7985-7994
-
-
Kutuk, O.1
Letai, A.2
-
17
-
-
70349694378
-
Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model
-
10.1158/1078-0432.CCR-09-0589 19773376
-
Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model. Kim KW, Moretti L, Mitchell LR, Jung DK, Lu B, Clin Cancer Res 2009 15 6096 6105 10.1158/1078-0432.CCR-09-0589 19773376
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6096-6105
-
-
Kim, K.W.1
Moretti, L.2
Mitchell, L.R.3
Jung, D.K.4
Lu, B.5
-
18
-
-
24744446473
-
Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells
-
DOI 10.1158/0008-5472.CAN-04-3553
-
Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. Burdette JE, Jeruss JS, Kurley SJ, Lee EJ, Woodruff TK, Cancer Res 2005 65 7968 7975 16140969 (Pubitemid 41297276)
-
(2005)
Cancer Research
, vol.65
, Issue.17
, pp. 7968-7975
-
-
Burdette, J.E.1
Jeruss, J.S.2
Kurley, S.J.3
Lee, E.J.4
Woodruff, T.K.5
-
19
-
-
77956173218
-
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta- mediated cyclin D1 overexpression
-
10.1038/onc.2010.238 20562919
-
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta- mediated cyclin D1 overexpression. Shimura T, Kakuda S, Ochiai Y, Nakagawa H, Kuwahara Y, Takai Y, Kobayashi J, Komatsu K, Fukumoto M, Oncogene 2010 29 4826 4837 10.1038/onc.2010.238 20562919
-
(2010)
Oncogene
, vol.29
, pp. 4826-4837
-
-
Shimura, T.1
Kakuda, S.2
Ochiai, Y.3
Nakagawa, H.4
Kuwahara, Y.5
Takai, Y.6
Kobayashi, J.7
Komatsu, K.8
Fukumoto, M.9
-
20
-
-
77954163242
-
Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells
-
10.1111/j.1349-7006.2010.01552.x 20331635
-
Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells. Ho JN, Kang GY, Lee SS, Kim J, Bae IH, Hwang SG, Um HD, Cancer Sci 2010 101 1417 1423 10.1111/j.1349-7006.2010.01552.x 20331635
-
(2010)
Cancer Sci
, vol.101
, pp. 1417-1423
-
-
Ho, J.N.1
Kang, G.Y.2
Lee, S.S.3
Kim, J.4
Bae, I.H.5
Hwang, S.G.6
Um, H.D.7
-
21
-
-
0033198110
-
Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells
-
DOI 10.1016/S0959-8049(99)00134-3, PII S0959804999001343
-
Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. Lee JU, Hosotani R, Wada M, Doi R, Kosiba T, Fujimoto K, Miyamoto Y, Tsuji S, Nakajima S, Nishimura Y, Imamura M, Eur J Cancer 1999 35 1374 1380 10.1016/S0959-8049(99)00134-3 10658530 (Pubitemid 29397439)
-
(1999)
European Journal of Cancer
, vol.35
, Issue.9
, pp. 1374-1380
-
-
Lee, J.-U.1
Hosotani, R.2
Wada, M.3
Doi, R.4
Kosiba, T.5
Fujimoto, K.6
Miyamoto, Y.7
Tsuji, S.8
Nakajima, S.9
Nishimura, Y.10
Imamura, M.11
-
22
-
-
0037386761
-
Low-dose fractionated radiation potentiates the effects of paclitaxel in wild-type and mutant p53 head and neck tumor cell lines
-
Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Dey S, Spring PM, Arnold S, Valentino J, Chendil D, Regine WF, Mohiuddin M, Ahmed MM, Clin Cancer Res 2003 9 1557 1565 12684432 (Pubitemid 36418414)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.4
, pp. 1557-1565
-
-
Dey, S.1
Spring, P.M.2
Arnold, S.3
Valentino, J.4
Chendil, D.5
Regine, W.F.6
Mohiuddin, M.7
Ahmed, M.M.8
-
23
-
-
79955098395
-
DNA repair and tumour radiosensitivity: Focus on ATM gene
-
21466987
-
DNA repair and tumour radiosensitivity: focus on ATM gene. Hennequin C, Quero L, Favaudon V, Bull Cancer 2011 98 239 246 21466987
-
(2011)
Bull Cancer
, vol.98
, pp. 239-246
-
-
Hennequin, C.1
Quero, L.2
Favaudon, V.3
-
24
-
-
1242338149
-
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy
-
DOI 10.1016/j.ijrobp.2003.07.010
-
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Ang KK, Andratschke NH, Milas L, Int J Radiat Oncol Biol Phys 2004 58 959 965 10.1016/j.ijrobp.2003.07.010 14967456 (Pubitemid 38221156)
-
(2004)
International Journal of Radiation Oncology Biology Physics
, vol.58
, Issue.3
, pp. 959-965
-
-
Ang, K.K.1
Andratschke, N.H.2
Milas, L.3
-
25
-
-
67349249819
-
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy
-
18516673
-
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy. Yang Q, Moran MS, Haffty BG, Breast Cancer Res Treat 2008 115 343 348 18516673
-
(2008)
Breast Cancer Res Treat
, vol.115
, pp. 343-348
-
-
Yang, Q.1
Moran, M.S.2
Haffty, B.G.3
-
26
-
-
70450285202
-
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis
-
10.1186/1748-717X-4-47 19852810
-
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis. Zerp SF, Stoter R, Kuipers G, Yang D, Lippman ME, Van Blitterswijk WJ, Bartelink H, Rooswinkel R, Lafleur V, Verheij M, Radiat Oncol 2009 4 47 10.1186/1748-717X-4-47 19852810
-
(2009)
Radiat Oncol
, vol.4
, pp. 47
-
-
Zerp, S.F.1
Stoter, R.2
Kuipers, G.3
Yang, D.4
Lippman, M.E.5
Van Blitterswijk, W.J.6
Bartelink, H.7
Rooswinkel, R.8
Lafleur, V.9
Verheij, M.10
|